Where is the live CopyMark page for USPTO serial 75493513?

The live record is at https://getcopymark.com/trademark/75493513. Use https://getcopymark.com/trademark/{serialNumber} for any 8-digit USPTO serial.

Who owns IMMUNOGENEX?

According to the public USPTO record for serial number 75493513, the listed owner(s) include: IMMUNOGENEX, INC..

What is USPTO serial number 75493513?

Serial number 75493513 is the USPTO application identifier for the mark IMMUNOGENEX. It is used to track examination, publication, and registration of this trademark.

Which trademark classes cover IMMUNOGENEX?

The public record lists International Classes: 001, 005, 010. Each class corresponds to categories of goods or services identified in the application or registration.

Trademark: IMMUNOGENEX Serial# 75493513 | status 601; last event ABN1 | Trademark Info & Attorney Guidance

Q: What is the current status of IMMUNOGENEX?

IMMUNOGENEX (75493513) currently shows USPTO status code 601 on the public record. This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with IMMUNOGENEX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner

Monitor this mark, or talk with CopyMark about this registration.

Trademark Monitoring

(312) 319-4460

Not the owner?

File a new U.S. trademark application, or speak with our attorneys.

Start a new application

(312) 319-4460

Owner

IMMUNOGENEX, INC.
San Diego, CA
Other trademarks owned by IMMUNOGENEX, INC.

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

John M. Kim

JOHN M KIM GRAY CARY WARE & FREIDENRICH LLP401 B ST STE 1700SAN DIEGO, CA 92101-4297UNITED STATES

Goods and services

Class	Description	Status	First use
001	Reagents for scientific or research use	ACTIVE	—
005	Diagnostic test kits consisting primarily of diagnostic preparations, namely, immunoassays, designed to detect cancer tumors and other aberrant cell growth that can cause a variety of cancers and other autoimmune diseases, all for non-medical scientific and research use	ACTIVE	—
010	Medical diagnostic test kits consisting primarily of diagnostic preparations, namely, immunoassays, designed to detect cancer tumors and other aberrant cell growth that can cause a variety of cancers and other autoimmune diseases, all for scientific and research use	ACTIVE	—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Date	Code	Event	What it means
Jun 13, 2001	ABN1	ABANDONMENT - EXPRESS MAILED	—
Mar 29, 2000	CNFR	FINAL REFUSAL MAILED	A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 7, 2000	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Nov 18, 1999	CNRT	NON-FINAL ACTION MAILED	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 17, 1999	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Mar 17, 1999	CNRT	NON-FINAL ACTION MAILED	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 2, 1999	DOCK	ASSIGNED TO EXAMINER	—
Feb 17, 1999	DOCK	ASSIGNED TO EXAMINER	—
Feb 5, 1999	DOCK	ASSIGNED TO EXAMINER	—

IMMUNOGENEX